<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04947748</url>
  </required_header>
  <id_info>
    <org_study_id>1</org_study_id>
    <nct_id>NCT04947748</nct_id>
  </id_info>
  <brief_title>Short Post-operative Antibacterial Therapy in Complicated Appendicitis: Oral Versus Intravenous</brief_title>
  <official_title>Short Post-operative Antibacterial Therapy in Complicated Appendicitis: Oral Versus Intravenous</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>North Estonia Medical Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tartu University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>North Estonia Medical Centre</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Short Post-operative Antibacterial Therapy in Complicated Appendicitis: Oral Versus&#xD;
      Intravenous is a prospective randomized controlled trial comparing 24 hour intravenous&#xD;
      antibacterial therapy to 24 hour oral antibacterial therapy after surgery in complicated&#xD;
      appendicitis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>RCT</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Infectious complications</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Acute Appendicitis</condition>
  <condition>Acute Appendicitis With Rupture</condition>
  <condition>Acute Appendicitis Without Peritonitis</condition>
  <condition>Acute Appendicitis With Appendix Abscess</condition>
  <condition>Appendicitis; Perforation</condition>
  <condition>Appendicitis Perforated</condition>
  <condition>Appendicitis Acute</condition>
  <arm_group>
    <arm_group_label>24 hour intravenous antibacterial therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>S.Augmentin 1,2g x 3 i/v</description>
  </arm_group>
  <arm_group>
    <arm_group_label>24 hour oral antibacterial therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>T.Augmentin 1g x 3 p/o</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oral versus intravenous administration of antibacterial treatment</intervention_name>
    <description>Mode of administration of antibacterial treatment</description>
    <arm_group_label>24 hour intravenous antibacterial therapy</arm_group_label>
    <arm_group_label>24 hour oral antibacterial therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients diagnosed with acute appendicitis and are candidates for laparoscopic&#xD;
        appendectomy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients with compromised immune system (HIV, diabetes), ongoing or completed&#xD;
        radio-chemotherapy in past 5 years, prosthetic heart valve, vascular prosthesis, pregnancy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edgar Lipping, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>North Estonia Medical Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Edgar Lipping, MD</last_name>
    <phone>6171520</phone>
    <email>edgar.lipping@regionaalhaigla.ee</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sten Saar, MD, PhD</last_name>
    <phone>6171520</phone>
    <email>sten.saar@regionaalhaigla.ee</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>North Estonia Medical Centre</name>
      <address>
        <city>Tallin</city>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edgar Lipping, MD</last_name>
      <phone>6171520</phone>
      <email>edgar.lipping@regionaalhaigla.ee</email>
    </contact>
    <contact_backup>
      <last_name>Sten Saar, MD, PhD</last_name>
      <phone>6171520</phone>
      <email>sten.saar@regionaalhaigla.ee</email>
    </contact_backup>
    <investigator>
      <last_name>Edgar Lipping, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sten Saar, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Estonia</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 24, 2021</study_first_submitted>
  <study_first_submitted_qc>June 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2021</study_first_posted>
  <last_update_submitted>June 24, 2021</last_update_submitted>
  <last_update_submitted_qc>June 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Appendicitis</mesh_term>
    <mesh_term>Peritonitis</mesh_term>
    <mesh_term>Acute Disease</mesh_term>
    <mesh_term>Rupture</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

